Cargando…

Dyslipidaemia Is Associated with Severe Disease Activity and Poor Prognosis in Ulcerative Colitis: A Retrospective Cohort Study in China

Background: Clinical data on the correlation of dyslipidaemia with the long-term outcomes of ulcerative colitis (UC) are limited. This study aimed to evaluate the impact of lipid levels on disease activity and prognosis in UC. Methods: The retrospective data of UC patients who had detailed lipid pro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Zhaoshi, Tang, Hao, Liang, Haozheng, Bai, Xiaoyin, Zhang, Huimin, Yang, Hong, Wang, Hongying, Wang, Li, Qian, Jiaming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9330762/ https://www.ncbi.nlm.nih.gov/pubmed/35893893 http://dx.doi.org/10.3390/nu14153040

Ejemplares similares

Sex-specific comparison of clinical characteristics and prognosis in Crohn’s disease: A retrospective cohort study of 611 patients in China
por: Liu, Zhaoshi, et al.
Publicado: (2022)

Artificial Neural Network Analysis-Based Immune-Related Signatures of Primary Non-Response to Infliximab in Patients With Ulcerative Colitis
por: Chen, Xuanfu, et al.
Publicado: (2021)

Bowel ultrasound enhances predictive value based on clinical indicators: a scoring system for moderate-to-severe endoscopic activities in patients with ulcerative colitis
por: Zhang, Mengmeng, et al.
Publicado: (2021)

Retrospective analysis of Clostridium difficile infection in patients with ulcerative colitis in a tertiary hospital in China
por: Xu, Hui, et al.
Publicado: (2019)

Has infliximab influenced the course and prognosis of acute severe ulcerative colitis?
por: Viscido, Angelo, et al.
Publicado: (2019)

The ulcerative colitis endoscopic index of severity score is superior to reflecting long-term prognosis in ulcerative colitis patients treated with vedolizumab
por: Yan, Jing, et al.
Publicado: (2023)

Diabetic dyslipidaemia
por: C. Thambiah, Subashini, et al.
Publicado: (2021)

Saccharomyces boulardii alleviates ulcerative colitis carcinogenesis in mice by reducing TNF-α and IL-6 levels and functions and by rebalancing intestinal microbiota
por: Wang, Chunsaier, et al.
Publicado: (2019)

Developing an instrument to assess the endoscopic severity of ulcerative colitis: the Ulcerative Colitis Endoscopic Index of Severity (UCEIS)
por: Travis, Simon P L, et al.
Publicado: (2011)

The year in dyslipidaemia 2008 /
Publicado: (2009)

The year in dyslipidaemia 2007
Publicado: (2008)

Treatment of Dyslipidaemia in Children
por: Fiorentino, Riccardo, et al.
Publicado: (2021)

Malnutrition Defined by the Global Leadership Initiative on Malnutrition (GLIM) Criteria in Hospitalized Patients with Ulcerative Colitis and Its Association with Clinical Outcomes
por: Wei, Wei, et al.
Publicado: (2023)

Comparison of the Mayo Endoscopy Score and the Ulcerative Colitis Endoscopy Index of Severity and the Ulcerative Colitis Colonoscopy Index of Severity
por: Belvis Jiménez, María, et al.
Publicado: (2021)

Cutaneous thrombotic vasculopathy related to poorly controlled ulcerative colitis
por: Cheeley, Justin, et al.
Publicado: (2018)

Inflammatory Indexes for Assessing the Severity and Disease Progression of Ulcerative Colitis: A Single-Center Retrospective Study
por: Lin, Hanyang, et al.
Publicado: (2022)

Tofacitinib in Steroid-Refractory Acute Severe Ulcerative Colitis: A Retrospective Analysis
por: Malakar, Sayan, et al.
Publicado: (2023)

Endoscopic ultrasonography in the evaluation of condition and prognosis of ulcerative colitis
por: Jin, Rui-Fang, et al.
Publicado: (2022)

The Changing Prognosis of Ulcerative Colitis and Crohn Disease by Decades
por: Korelitz, Burton I, et al.
Publicado: (2021)

Trajectory of fecal lactoferrin for predicting prognosis in ulcerative colitis
por: Chen, Rirong, et al.
Publicado: (2023)

Ulcerative Colitis-Symptom Questionnaire: Valid for Use in Adults with Moderately to Severely Active Ulcerative Colitis
por: Panes, Julian, et al.
Publicado: (2023)

Effectiveness and safety of vedolizumab for ulcerative colitis: a single-center retrospective real-world study in China
por: Huang, Kaituo, et al.
Publicado: (2023)

Probiotic mixture VSL#3 prevents ulcerative colitis-associated carcinogenesis in mice and cells by regulating the inflammatory and Wnt/β-catenin pathway
por: Li, Wenbin, et al.
Publicado: (2022)

Risk factors, comorbiditiEs and Atherogenic dysLipidaemia in Indian YOUNG patients with dyslipidaemia attending hospital/clinic: REAL YOUNG (dyslipidaemia) study
por: Iyengar, S. S., et al.
Publicado: (2020)

Comparing the clinical application values of the Degree of Ulcerative Colitis Burden of Luminal Inflammation (DUBLIN) score and Ulcerative Colitis Endoscopic Index of Severity (UCEIS) in patients with ulcerative colitis
por: Zhang, Xiao-Fei, et al.
Publicado: (2021)

What is the "optimal formula" for donor selection and feces processing for fecal microbiota transplantation in ulcerative colitis?
por: Li, Haiyue, et al.
Publicado: (2023)

The year in dyslipidaemia : version en español 2009-2010 /
Publicado: (2010)

Assessing Severity of Disease in Patients with Ulcerative Colitis
por: Pabla, Baldeep Singh, et al.
Publicado: (2020)

Dyslipidaemia in Rheumatological Autoimmune Diseases
por: Toms, Tracey E, et al.
Publicado: (2011)

The year in dyslipidaemia 2005-2006
Publicado: (2006)

Angina due to hypertension and dyslipidaemia
por: Fox, Kim
Publicado: (2019)

Nutraceuticals in Paediatric Patients with Dyslipidaemia
por: Banderali, Giuseppe, et al.
Publicado: (2022)

Fixed Combination for the Treatment of Dyslipidaemia
por: Ferri, Nicola, et al.
Publicado: (2023)

The relationships of shift work, hair cortisol concentration and dyslipidaemia: a cohort study in China
por: Zhu, Lejia, et al.
Publicado: (2022)

Prognosis following emergency surgery for ulcerative colitis in elderly patients
por: Ikeuchi, Hiroki, et al.
Publicado: (2013)

Prevalence of dyslipidaemia in statin-treated patients in South Africa: results of the DYSlipidaemia International Study (DYSIS)
por: Raal, Frederick J, et al.
Publicado: (2013)

Use of Novel Biological Agent in Severe Ulcerative Colitis with Poor Response to Initial Therapy: A Case Report
por: Bhandari, Abashesh, et al.
Publicado: (2022)

Correlation of Biomarkers with Endoscopic Score: Ulcerative Colitis Endoscopic Index of Severity (UCEIS) in Patients with Ulcerative Colitis in Remission
por: Pop, Corina Silvia, et al.
Publicado: (2020)

Body Composition Changes and Related Factors in Patients with Ulcerative Colitis: A Retrospective Single-Center Study in China
por: Wang, Rongyu, et al.
Publicado: (2022)

Retrospective investigation of mesalamine intolerance in patients with ulcerative colitis
por: Minagawa, Yuki, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_usodare1s6vgag57mvfe02q0p1